Search NLS News

The company has reported results from its ARIA-1 study in healthy volunteers with the drug candidate AQ280, a selective proprietary JAK1 inhibitor, being developed as a treatment for eosinophilic esophagitis (EoE) within the Regulus program. Healthy subjects were administered single or multiple doses in a sequential escalating dosing schedule until the maximum planned dose of […]

Thermo Fisher Scientific and Olink Holding have announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for USD 26.00 per common share in cash, representing USD 26.00 per American Depositary Share (ADS) in cash. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common […]

Anna Falk, professor at Lund University’s Stem Cell Center, will be the director of the newly established Center for Advanced Therapies, LU-ATMP. “My vision is that we will accelerate the development of all the advanced therapies underway at Lund University. Together with the healthcare and life science industry, we have the potential to make a […]

TIME has selected lecanemab as one of the best inventions of 2023 in the Medical Care category. Lecanemab is based on BioArctic’s founder Professor Lars Lannfelt’s research. It is the first and only fully approved treatment in the US and Japan for patients with mild cognitive impairment or mild Alzheimer’s disease that targets the underlying […]

Professor of Biometry, Samuli Ripatti, has been appointed the new Director of the Institute for Molecular Medicine Finland (FIMM). According to Jari Koistinaho, Director of the Helsinki Institute of Life Sciences HiLIFE, Ripatti’s recruitment is an important step in further strengthening the life sciences portfolio of the University of Helsinki. “We have recruited a new director […]

The Prix Galien USA Committees honored excellence and innovation in life sciences during the Prix Galien USA Forum and 17h annual Prix Galien Awards Gala last week at the American Museum of Natural History in New York City. The USA Committees, composed of 20 committee members, 12 subcommittee members and 20 advisory board members, represented […]

Julia Macharey has been appointed Senior Vice President of Orion Group’s new People & Culture group-level function and member of the Executive Management Board of Orion Group as of February 1st 2024. “With this appointment, I wanted to support the implementation of our global growth strategy and to strengthen the building of Orion’s corporate culture. […]

The Icelandic digital health company has acquired aidhere, a developer of prescription digital therapeutics based in Germany. The acquisition strengthens Sidekick Health’s digital health offering to patients and partners with this leading prescription digital therapeutics (PDT) company, it states. aidhere brings with it zanadio, that has fulfilled over 50,000 prescriptions and is recognized within Germany’s […]

NLS asked Dominykas Milašius, Venture Partner at Baltic Sandbox Ventures and co-founder of Delta biosciences, about the Baltic business climate for life science startups and companies, and opportunities for investments and collaborations in Estonia, Latvia and Lithuania. Describe Baltic Sandbox Ventures’ investments in life science companies/startups? What kind of companies are you focusing your investments […]

The company has announced that a Private Placement has been successfully placed, raising approximately NOK 505 million in gross proceeds through the allocation of 29,549,400 new shares at a subscription price of NOK 17.10 per share. “We are pleased with the strong support Nykode has received from a group of international specialist investors and our […]